1-7 of 7
Keywords: Glucocorticoids
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles
Subject Area:
Dermatology , Pharmacology
Skin Pharmacol Physiol (2021) 34 (1): 30–37.
Published Online: 16 February 2021
...Valerie Bernays; Mariusz Pawel Kowalewski; Ioannis Dedes; Katrin Kerl French; Daniel Fink; Isabel Kolm; Cornelia Betschart Background: Chronic vulvar dermatitis (CVD) is the most prevalent disease in gynecologic dermatology. The treatment mainly depends on topical glucocorticoids (TGC...
Journal Articles
Subject Area:
Dermatology , Pharmacology
Skin Pharmacol Physiol (2018) 31 (4): 188–197.
Published Online: 26 April 2018
..., the mechanism of mast cell activation is unclear. In this study, we examined the mechanism underlying the formation of dry skin induced by mast cells in arthritis that involves thymic stromal lymphopoietin (TSLP), neutrophils, reactive oxygen species (ROS), and glucocorticoids. Methods: Mice with DBA/1JJmsSlc...
Journal Articles
Subject Area:
Dermatology , Pharmacology
Skin Pharmacol Physiol (2011) 24 (4): 199–209.
Published Online: 24 February 2011
... enhancement, 3 glucocorticoids (GCs), prednisolone (PD), the diester prednicarbate (PC) and the monoester betamethasone 17-valerate (BMV), varying in structure and lipophilicity, were loaded onto SLNs. Theoretical permeability coefficients (cm/s) of the agents rank BMV (–6.38) ≧ PC (–6.57) > PD (–7.30). GC...
Journal Articles
Subject Area:
Dermatology , Pharmacology
Skin Pharmacology (1996) 9 (2): 93–98.
Published Online: 31 March 2009
... contribute to mast cell-dependent pathology. In the present study, we have investigated the influence of four potent glucocorticoids, methylprednisolone-aceponate, methylprednisolone-17-propionate, prednicarbate, and betametasone valerate (10 5 M -10 -9 M ), on the IL-1Β, IL-3, IL-8, and tumor necrosis...
Journal Articles
Journal Articles
Subject Area:
Dermatology , Pharmacology
Skin Pharmacol Physiol (2005) 18 (3): 103–114.
Published Online: 06 May 2005
...M. Schäfer-Korting; B. Kleuser; M. Ahmed; H.-D. Höltje; H.C. Korting Topical glucocorticoids have always been considered first-line drugs for inflammatory diseases of the skin and bronchial system. Applied systemically, glucocorticoids are used for severe inflammatory and immunological diseases...
Journal Articles
Subject Area:
Dermatology , Pharmacology
Skin Pharmacology and Applied Skin Physiology (2003) 16 (3): 143–150.
Published Online: 11 April 2003
...I. Spika; S. Hammer; B. Kleuser; H.C. Korting; M. Schäfer-Korting As compared to standard glucocorticoids (GC), prednicarbate (PC) is favorable in the treatment of eczema due to its high benefit/risk ratio. The remarkable anti-inflammatory effects of PC are in strong contrast to its reported low...